Leaflet NORMOSANG 25mg / ml concentrate for solution for infusion

Product code: W59828001

Indicated for: acute hepatic porphyria

Route of administration: infusion

Substance: human hemin (hemostatic agent)

ATC: B06AB (Blood and blood forming organs | Other hematological agents | Other hematological agents | Heme products)

Human hemin is a medication used for the treatment of acute intermittent porphyria, a rare metabolic disorder caused by an enzymatic deficiency in heme synthesis. It helps reduce the production of toxic precursors that cause the symptoms of the disease.

The medication is administered via intravenous infusion and is most effective when given at the onset of symptoms. Treatment must be carried out under the supervision of a specialist experienced in rare metabolic diseases.

Common side effects include phlebitis at the infusion site, nausea, and abdominal pain. In rare cases, severe allergic reactions may occur, and patients should be closely monitored.

Human hemin is an essential therapeutic option for patients with acute porphyria, helping to reduce the severity and duration of acute episodes.

General data about NORMOSANG 25mg / ml

  • Substance: human hemin
  • Product code: W59828001
  • Concentration: 25mg / ml
  • Pharmaceutical form: concentrate for solution for infusion
  • Quantity: 0
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ORPHAN EUROPE - FRANTA
  • Holder: CN UNIFARM S.A. - ROMANIA
  • Number: 321/2017/01
  • Shelf life: 2 years